Rethinking Vaccine Strategy In Emerging Markets Offers Strong Growth Opportunities
This article was originally published in PharmAsia News
Executive Summary
CAMBRIDGE, Mass. -The vaccine industry has enjoyed a resurgence in recent years as Big Pharma realized a vaccines business can be a profit center as well as a social good, but the new vaccines era comes with its own set of challenges and growth opportunities